Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer trials recruiting in Maine

Fewer than 3 recruiting trials found.

All Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer trials nationally

Cities in Maine

Recruiting trials in Maine

• A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
  NCT06065748 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Maine: Scarborough